Our data suggest that compared with the subcutaneous route of administratio
n, intravenous vitamin K-1 results in a more prompt reduction in the intern
ational normalized ration. However, for most patients, subcutaneous vitamin
K-1 is an effective and safe alternative when used in conjunction with mod
ification of subsequent warfarin dosing, because virtually all patients ach
ieved a safe level of anticoagulation within 72 hours with this route of ad
ministration.